Category Pharmaceuticals and Biotech

Simplifying Clinical Data Flow From EDC to SDTM, New Webinar Hosted by Xtalks
Press Release -

Simplifying Clinical Data Flow From EDC to SDTM, New Webinar Hosted by Xtalks

5 lessons to master clinical data aggregation, transformation, cleaning and analytics to reduce cost, risk and time

MedEvoke Broadens Its Medical Affairs Reach With Expanded Leadership Roles
Press Release -

MedEvoke Broadens Its Medical Affairs Reach With Expanded Leadership Roles

MedEvoke, a premier provider of globally aligned, evidence-based scientific narrative development for the biopharmaceutical industry is now poised to broaden its reach with burgeoning new business, and expanded leadership roles will impact the company's scope in key growth areas: servicing global initiatives, and creating brand awareness across the therapeutic landscape.

Virtual Distance International and Stockholm School of Economics Executive Education Expands Partnership to Provide Unique Solutions to Digital-Age Distance Leadership Challenges in the Nordic Countries
Press Release -

Virtual Distance International and Stockholm School of Economics Executive Education Expands Partnership to Provide Unique Solutions to Digital-Age Distance Leadership Challenges in the Nordic Countries

The partnership is focused on reducing the impact of Virtual Distance and increasing key performance indicators for Stockholm School of Economics Executive Education participants.

Dante Labs Offers $199 Whole Genome Sequencing Promotion for Black Friday Week
Press Release -

Dante Labs Offers $199 Whole Genome Sequencing Promotion for Black Friday Week

Dante Labs, an international leader in bringing affordable Whole Genome Sequencing (WGS) to consumers, is excited to announce the launch of their USD 199/ EUR 169 Black Friday promotion. The promotion is set to bring an easy ability for anybody to put a premium on their health and wellness and that of their loved ones this holiday season.

Press Release -

GeneTex Partners With BenchSci to Augment Antibody Catalog Publication Data

Partnership will use BenchSci's artificial intelligence to help researchers run successful experiments with the right antibody

Press Release -

EastGate Biotech Appoints World-Renowned Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives

Key Opinion Leader spreading awareness of diabetes endorses the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients

Lotus Clinical Research LLC Receives Private Equity Backing
Press Release -

Lotus Clinical Research LLC Receives Private Equity Backing

Lotus Clinical Research LLC receives private equity backing; expands team with Jeffrey Kinell and Kurt Brykman joining board of directors

International Association of Women Recognizes Debra Robinson as a 2018-2019 Influencer
Press Release -

International Association of Women Recognizes Debra Robinson as a 2018-2019 Influencer

Debra Robinson, MBA, MPM, PMP, Sr. Director, Program and Alliance Management at Maverick Therapeutics, joins networking organization

Expediting Dry Powder Inhaler Formulation Development Through Modelling and Advanced Characterization, New Webinar Hosted by Xtalks
Press Release -

Expediting Dry Powder Inhaler Formulation Development Through Modelling and Advanced Characterization, New Webinar Hosted by Xtalks

Dry powder inhalers are gaining increasing momentum for drug delivery to the lungs. One of the most used and flexible delivery technologies are capsule-based dry powder inhalers

Press Release -

World's Largest Newborn Screening Study for Four Rare Disorders Launches

Nonprofits co-fund feasibility study to test screening tool for 75,000 newborns for Angelman, Prader-Willi, Fragile X and Dup15q Syndromes

Development of Long-Acting Local Anesthetics
Press Release -

Development of Long-Acting Local Anesthetics

Lotus Clinical Research Presented at Pain Therapeutics in San Francisco on Development of Long-Acting Local Anesthetics

Dr. Steven Passik Has Joined the Scientific Advisory Board of Bridge Therapeutics
Press Release -

Dr. Steven Passik Has Joined the Scientific Advisory Board of Bridge Therapeutics

Bridge Therapeutics Announces the Addition of Dr. Steve Passik to Its Scientific Advisory Board

Letters From Generation Rx, Family Tragedies Mark the Dark Side of Psychiatric Drugs on DOCUMENTARY SHOWCASE
Press Release -

Letters From Generation Rx, Family Tragedies Mark the Dark Side of Psychiatric Drugs on DOCUMENTARY SHOWCASE

Letters from Generation Rx, a powerful look at the mortal dangers for children who have been prescribed anti-depressant drugs.

Drug Development - the 6 Most Critical Reasons Why Drugs Are Delayed When Planning and Conducting CTA/IND Enabling Studies, New Webinar Hosted by Xtalks
Press Release -

Drug Development - the 6 Most Critical Reasons Why Drugs Are Delayed When Planning and Conducting CTA/IND Enabling Studies, New Webinar Hosted by Xtalks

Bringing a drug from discovery to market is an expensive and time-consuming business. Every drug that fails comes with a cost which could be both reputational and financial. Keeping your development program on track is therefore critical to success.

Press Release -

Nurocor Partners With Intilaris to Accelerate Clinical Trials

Companies to collaborate to accelerate the use of standards in the planning stage of clinical trials

Press Release -

Bridge Therapeutics Announces the Addition of Dr. Bob Rappaport to Its Scientific Advisory Board

Dr. Bob Rappaport joins Bridge Therapeutics' Scientific Advisory Board as its newest member

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018
Press Release -

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018

Parnell delivers 39% revenue growth and a $5.9 million year-to-date improvement in EBITDA as at the third quarter of 2018 compared to the same period in 2017, consolidates the return to profitability, and maintains full-year 2018 guidance at a 35 - 40% increase over 2017 revenue to $26 - $27 million and an EBITDA range of $5.5 - $6.5 million.

Press Release -

Bridge Therapeutics is Selected as a Finalists for the RESI 2018 Innovation Challenge

Bridge Therapeutics will present a poster presentation at the RESI Conference November 4, 2018, in New York.

L.A. Startup Pays Employees to Go on Vacation
Press Release -

L.A. Startup Pays Employees to Go on Vacation

24-year-old founder begins paying employees to take vacations to improve business productivity